299 related articles for article (PubMed ID: 31681185)
1. Progress in Allogeneic Hematopoietic Cell Transplantation in Adult T-Cell Leukemia-Lymphoma.
Utsunomiya A
Front Microbiol; 2019; 10():2235. PubMed ID: 31681185
[TBL] [Abstract][Full Text] [Related]
2. Clinical impact of the CONUT score and mogamulizumab in adult T cell leukemia/lymphoma.
Ureshino H; Kusaba K; Kidoguchi K; Sano H; Nishioka A; Itamura H; Yoshimura M; Yokoo M; Shindo T; Kubota Y; Ando T; Kojima K; Sueoka E; Kimura S
Ann Hematol; 2019 Feb; 98(2):465-471. PubMed ID: 30264165
[TBL] [Abstract][Full Text] [Related]
3. The Impact of a Humanized CCR4 Antibody (Mogamulizumab) on Patients with Aggressive-Type Adult T-Cell Leukemia-Lymphoma Treated with Allogeneic Hematopoietic Stem Cell Transplantation.
Kawano N; Kuriyama T; Yoshida S; Kawano S; Yamano Y; Marutsuka K; Minato S; Yamashita K; Ochiai H; Shimoda K; Ishikawa F; Kikuchi I
J Clin Exp Hematop; 2017; 56(3):135-144. PubMed ID: 28331127
[TBL] [Abstract][Full Text] [Related]
4. Lenalidomide treatment for recurrent adult T-cell leukemia/lymphoma after allogeneic hematopoietic cell transplantation.
Tanaka T; Inamoto Y; Ito A; Watanabe M; Takeda W; Aoki J; Kim SW; Fukuda T
Hematol Oncol; 2023 Aug; 41(3):389-395. PubMed ID: 36513602
[TBL] [Abstract][Full Text] [Related]
5. Prevention of acute graft-versus-host disease in adult T-cell leukemia-lymphoma patients who received mogamulizumab before allogeneic hematopoietic cell transplantation.
Inoue Y; Nishimura N; Murai M; Matsumoto M; Watanabe M; Yamada A; Izaki M; Nosaka K; Matsuoka M
Int J Hematol; 2022 Mar; 115(3):435-439. PubMed ID: 34705226
[TBL] [Abstract][Full Text] [Related]
6. Friend or foe? Mogamulizumab in allogeneic hematopoietic stem cell transplantation for adult T-cell leukemia/lymphoma.
Fuji S; Shindo T
Stem Cell Investig; 2016; 3():70. PubMed ID: 27868052
[TBL] [Abstract][Full Text] [Related]
7. A retrospective analysis of treatment outcomes in adult T cell leukemia/lymphoma patients with aggressive disease treated with or without allogeneic stem cell transplantation: A single-center experience.
Kawada H; Yoshimitsu M; Nakamura D; Arai A; Hayashida M; Kamada Y; Maekawa K; Fujino S; Arima M; Arima N; Tabuchi T; Inoue H; Hamda H; Suzuki S; Matsushita K; Arima N
Biol Blood Marrow Transplant; 2015 Apr; 21(4):696-700. PubMed ID: 25542158
[TBL] [Abstract][Full Text] [Related]
8. A retrospective analysis of allogeneic hematopoietic stem cell transplantation for adult T cell leukemia/lymphoma (ATL): clinical impact of graft-versus-leukemia/lymphoma effect.
Shiratori S; Yasumoto A; Tanaka J; Shigematsu A; Yamamoto S; Nishio M; Hashino S; Morita R; Takahata M; Onozawa M; Kahata K; Kondo T; Ota S; Wakasa K; Sugita J; Koike T; Asaka M; Kasai M; Imamura M
Biol Blood Marrow Transplant; 2008 Jul; 14(7):817-23. PubMed ID: 18541202
[TBL] [Abstract][Full Text] [Related]
9. [Allogeneic hematopoietic stem cell transplantation for adult T-cell leukemia-lymphoma].
Utsunomiya A
Rinsho Ketsueki; 2016; 57(10):2190-2198. PubMed ID: 27795530
[TBL] [Abstract][Full Text] [Related]
10. [Impact of pretransplant anti-CCR4 antibody administration on clinical outcomes in allogeneic hematopoietic stem cell transplantation].
Fuji S
Rinsho Ketsueki; 2019; 60(8):968-972. PubMed ID: 31484897
[TBL] [Abstract][Full Text] [Related]
11. Outcomes in human T-cell leukemia virus type I carriers after hematopoietic stem cell transplantation for diseases other than adult T cell leukemia/lymphoma: a Japanese national survey.
Nakano N; Nakasone H; Fuji S; Shinohara A; Suzuki R; Utsunomiya A; Eto T; Morishima S; Ikegame K; Kakinoki Y; Matsuoka KI; Mori Y; Suehiro Y; Uchida N; Ito A; Doki N; Ozawa Y; Kanda J; Kanda Y; Fukuda T; Atsuta Y; Ogata M
Lancet Reg Health West Pac; 2023 Nov; 40():100902. PubMed ID: 38106528
[TBL] [Abstract][Full Text] [Related]
12. Impact of graft-versus-host disease on allogeneic hematopoietic cell transplantation for adult T cell leukemia-lymphoma focusing on preconditioning regimens: nationwide retrospective study.
Ishida T; Hishizawa M; Kato K; Tanosaki R; Fukuda T; Takatsuka Y; Eto T; Miyazaki Y; Hidaka M; Uike N; Miyamoto T; Tsudo M; Sakamaki H; Morishima Y; Suzuki R; Utsunomiya A
Biol Blood Marrow Transplant; 2013 Dec; 19(12):1731-9. PubMed ID: 24090597
[TBL] [Abstract][Full Text] [Related]
13. A Multicenter Retrospective Study of Mogamulizumab Efficacy in Adult T-Cell Leukemia/Lymphoma.
Iyama S; Sato T; Ohnishi H; Kanisawa Y; Ohta S; Kondo T; Mori A; Tsutsumi Y; Kuroda H; Kakinoki Y; Yamamoto S; Takahashi T; Shindo M; Torimoto Y; Sato K; Iwasaki H; Haseyama Y; Kohda K; Nagamachi Y; Hirayama Y; Sakai H; Hirata Y; Fukuhara T; Ikeda H; Kobune M; Kato J; Kurosawa M
Clin Lymphoma Myeloma Leuk; 2017 Jan; 17(1):23-30.e2. PubMed ID: 27727135
[TBL] [Abstract][Full Text] [Related]
14. [Adult T cell leukemia-lymphoma with allo-HSCT after treatment for pulmonary involvement with Mogamulizumab].
Kawashima I; Sueki Y; Yamamoto T; Nozaki Y; Nakajima K; Mitsumori T; Kirito K
Rinsho Ketsueki; 2015 Feb; 56(2):210-5. PubMed ID: 25765802
[TBL] [Abstract][Full Text] [Related]
15. Treatment of adult T-cell leukemia.
Uozumi K
J Clin Exp Hematop; 2010; 50(1):9-25. PubMed ID: 20505272
[TBL] [Abstract][Full Text] [Related]
16. Outcomes of Allogeneic Hematopoietic Stem Cell Transplantation for ATL with HTLV-1 Antibody-Positive Donors.
Yoshimitsu M; Fuji S; Utsunomiya A; Nakano N; Ito A; Ito Y; Miyamoto T; Suehiro Y; Kawakita T; Moriuchi Y; Nakamae H; Kanda Y; Ichinohe T; Fukuda T; Atsuta Y; Kato K;
Biol Blood Marrow Transplant; 2020 Apr; 26(4):718-722. PubMed ID: 31821886
[TBL] [Abstract][Full Text] [Related]
17. Adult T-Cell Leukemia-Lymphoma.
Munakata W; Tobinai K
Cancer Treat Res; 2019; 176():145-161. PubMed ID: 30596217
[TBL] [Abstract][Full Text] [Related]
18. Successful treatment strategy in corporating mogamulizumab and cord blood transplantation in aggressive adult T-cell leukemia-lymphoma: a case report.
Nakata K; Fuji S; Koike M; Tada Y; Masaie H; Yoshida H; Watanabe E; Kobayashi S; Tojo A; Uchimaru K; Ishikawa J
Blood Cell Ther; 2020 Feb; 3(1):6-10. PubMed ID: 37465376
[TBL] [Abstract][Full Text] [Related]
19. Improved survival of patients with aggressive ATL by increased use of allo-HCT: a prospective observational study.
Ito A; Nakano N; Tanaka T; Fuji S; Makiyama J; Inoue Y; Choi I; Nakamae H; Nagafuji K; Takase K; Machida S; Takahashi T; Sawayama Y; Kamimura T; Kato K; Kawakita T; Ogata M; Sakai R; Shiratori S; Uchimaru K; Inamoto Y; Utsunomiya A; Fukuda T
Blood Adv; 2021 Oct; 5(20):4156-4166. PubMed ID: 34500464
[TBL] [Abstract][Full Text] [Related]
20. Risk Assessment in Adult T Cell Leukemia/Lymphoma Treated with Allogeneic Hematopoietic Stem Cell Transplantation.
Yoshimitsu M; Tanosaki R; Kato K; Ishida T; Choi I; Takatsuka Y; Fukuda T; Eto T; Hidaka M; Uchida N; Miyamoto T; Nakashima Y; Moriuchi Y; Nagafuji K; Miyazaki Y; Ichinohe T; Takanashi M; Atsuta Y; Utsunomiya A;
Biol Blood Marrow Transplant; 2018 Apr; 24(4):832-839. PubMed ID: 29155320
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]